In vivo and in vitro characterization of site-specific recombination of a novel serine integrase from the temperate phage EFC-1
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Yoon, Bohyun | - |
dc.contributor.author | Kim, Inki | - |
dc.contributor.author | Nam, Ja-Ae | - |
dc.contributor.author | Chang, Hyo-Ihl | - |
dc.contributor.author | Ha, Chang Hoon | - |
dc.date.accessioned | 2021-09-04T00:26:19Z | - |
dc.date.available | 2021-09-04T00:26:19Z | - |
dc.date.created | 2021-06-17 | - |
dc.date.issued | 2016-04-22 | - |
dc.identifier.issn | 0006-291X | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/88900 | - |
dc.description.abstract | EFC-1 integrase is a site-specific recombinase that belongs to the large family of serine recombinase. In previously study, we isolated the temperate phage EFC-1, and characterized its genomic sequence. Within its genome, Orf28 was predicted encode a 464 amino acid of a putative integrase gene. In this study, EFC-1 integrase was characterized in vitro and in vivo. In vitro assay was performed using purified His-tag fusion integrase. Also, to identify which serine is involved in the catalytic domain, we used site directed mutagenesis and analyzed by a recombination assay in vitro. In vivo assay involved PCR and confocal microscopy in HEK293 cells, and determined the minimal lengths of attP and attB sites. According to our results, the EFC-1 integrase-mediated recombination was site-specific and unidirectional system in vitro and in vivo. Serine 21 of EFC-1 integrase plays a major role in the catalytic domain, and minimal sizes of attB and attP was defined 48 and 54 bp. Our finding may help develop a useful tool for gene therapy and gene delivery system. (C) 2016 Elsevier Inc. All rights reserved. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | ACADEMIC PRESS INC ELSEVIER SCIENCE | - |
dc.subject | POLYMERASE-CHAIN-REACTION | - |
dc.subject | GENOMIC INTEGRATION | - |
dc.subject | PHI-C31 INTEGRASE | - |
dc.subject | MAMMALIAN-CELLS | - |
dc.title | In vivo and in vitro characterization of site-specific recombination of a novel serine integrase from the temperate phage EFC-1 | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Chang, Hyo-Ihl | - |
dc.identifier.doi | 10.1016/j.bbrc.2016.03.106 | - |
dc.identifier.scopusid | 2-s2.0-84963642057 | - |
dc.identifier.wosid | 000374800700052 | - |
dc.identifier.bibliographicCitation | BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, v.473, no.1, pp.336 - 341 | - |
dc.relation.isPartOf | BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS | - |
dc.citation.title | BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS | - |
dc.citation.volume | 473 | - |
dc.citation.number | 1 | - |
dc.citation.startPage | 336 | - |
dc.citation.endPage | 341 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Biochemistry & Molecular Biology | - |
dc.relation.journalResearchArea | Biophysics | - |
dc.relation.journalWebOfScienceCategory | Biochemistry & Molecular Biology | - |
dc.relation.journalWebOfScienceCategory | Biophysics | - |
dc.subject.keywordPlus | POLYMERASE-CHAIN-REACTION | - |
dc.subject.keywordPlus | GENOMIC INTEGRATION | - |
dc.subject.keywordPlus | PHI-C31 INTEGRASE | - |
dc.subject.keywordPlus | MAMMALIAN-CELLS | - |
dc.subject.keywordAuthor | Integrase | - |
dc.subject.keywordAuthor | Serine recombinase | - |
dc.subject.keywordAuthor | Gene delivery system | - |
dc.subject.keywordAuthor | Gene therapy | - |
dc.subject.keywordAuthor | Site-directed mutagenesis | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.